Market the supervised program, not the drug. Build a dedicated tirzepatide page that answers cost, candidacy and the semaglutide comparison, run Google Ads on medical weight loss intent, and lead with what telehealth cannot offer: in-person monitoring and fast dose adjustments.
Not safely in ad copy. Google and Meta both treat tirzepatide as a prescription drug, and the brand names Mounjaro and Zepbound are trademarked, so ads that lean on them get disapproved or trigger pharmacy certification requirements that a local clinic does not want to deal with. The drug name belongs on your landing page and in your educational content, where it is accurate and helpful. The ads themselves should sell the program: medically supervised weight loss, GLP-1 weight loss program, physician-led weight management.
Four things patients are actually deciding on. Who is a candidate, with the BMI and health criteria your medical director uses. What the program costs per month and what that includes, because patients comparison-shop this harder than any aesthetic service. How tirzepatide compares to semaglutide, since most patients arrive having read both names. And what the first ninety days look like, including how dose adjustments and side effects are handled. A page that answers those four questions converts; a page that says 'contact us to learn more' sends the patient back to a telehealth site that publishes the price.
If any of this sounds like your practice, start by checking whether AI search can see your site.
The patient is usually a step further along. Semaglutide searches skew toward people new to GLP-1s. Tirzepatide searches skew toward people who already know the category, have often heard it produces more weight loss in trials, and are asking whether they qualify and what it costs. That means content should be comparison-heavy, pricing should be visible, and the clinic should be ready to explain why a patient might choose one over the other without making efficacy promises the ad platforms will flag.
Google Search first, every time. Someone typing 'tirzepatide clinic near me' or 'tirzepatide cost' is ready to book, and search is where in-person clinics beat telehealth, because the map pack and local results are something a national brand cannot occupy. SEO and AI search come second, through pages on cost, candidacy, side effects and the semaglutide comparison, which is what gets a clinic cited when a patient asks ChatGPT or Google's AI Overview who offers tirzepatide locally. Meta works, but as the third step once search is capped, with creative that complies with Meta's weight loss rules.
Give it its own lane. A separate landing page, a separate Google Ads campaign, its own line on your Google Business Profile services, and a medical director visibly attached to it. Patients who come for weight loss are a different audience from patients who come for Botox, and mixing them on one page weakens both. Done right, the weight loss program becomes the highest lifetime-value service the med spa offers, since a tirzepatide patient typically stays on therapy for a year or more.
Cost per booked consult, not cost per click. In most markets a clinic should expect the first month to be about data, the second to be about cutting the wasted spend that data exposes, and the third to be the first clean read on what a tirzepatide patient costs to acquire. Measured against twelve months of program revenue, the number is usually easy to defend.
Uday Rajaram is the founder of Medical Marketing Firm. He has spent 22 years in digital marketing, starting as a developer in New York, and has run Google Ads, SEO, and AI search programs for more than 100 medical and cosmetic practices. He is the author of Earned Traffic.
Every guide on this site is written or reviewed by him. The numbers come from our own client accounts and published case studies, never estimates. How we source and update our content · udayrajaram.com
Want me to look at your site the way I looked at this data? Check my site